Media · Insights
Insights
Writing and white papers from the team on how health markets get built.
9 pieces since 2025
More from the team
Perspectives on building health markets
How we are making pharmaceutical quality scalable and accessible with AI
How Axmed turns day-long manual prequalification and GMP and GDP audit work into real-time quality intelligence with AI. By Sofia Radley-Searle, COO.
Sofia Radley-Searle
The certificate was valid. The medicine was not.
Rethinking medicine quality in East Africa's supply chain: the medicine reached the patient, the label was correct, and it did not work.
Dr Onyango Michael
Access to healthcare will be won or lost on how markets are built
A persistent misconception holds that expanding access to healthcare requires sacrificing commercial viability. A year of operating says otherwise.
Felix Ohnmacht
Future-proofing health procurement in a post-US-aid world
The dust has begun to settle after a turbulent year in development financing. What comes next for the countries that depended on it?
Sofia Radley-Searle
Procurement as the invisible bottleneck in global health
Thousands of procurement units, hospitals and pharmacies still work in isolation. What AI can and cannot do about it. By Mattia Albergante, CTO of Axmed.
Mattia Albergante
PDFWhen will we see the full potential of vaccines?
In-house modelling suggests roughly 75 million more lives could have been saved over 50 years had vaccines been equitably available. An Axmed white paper.
Axmed Global Health Advisory
A wake-up call? Radical action for smarter medicine access
Global health procurement has relied on centralised institutions pooling donor funding. That system is unravelling, and the moment demands radical change.
From Citizen Digital
From crisis to opportunity: transforming access to medicines for the 21st century
Axmed CEO Emmanuel Akpakwu on how bold action, partnerships and technology can turn failures in healthcare access into opportunity. A syndicated article.
Axmed
Reading list
From the wider field
Research and reporting by other people, first published elsewhere. It informed how Axmed thinks about access, so we keep it here with a link to each original.
- Financial Times, republished by the Access to Medicine Foundation
Poor countries desperately need better access to generic medicines
- VoxEU, CEPR
Pooled procurement of drugs in low- and middle-income countries can lower prices and improve access
- U.S. Food and Drug Administration, via Alzheimers.gov
FDA grants accelerated approval for an Alzheimer's disease treatment
- Access to Medicine Foundation
Index finds more pharma companies moving to address access to medicine. Will they now go further?
Coronavirus hits America again
Drug shortages worsen in South Africa